SenesTech, Inc., an Arizona based life science company, today announced a series of significant changes and additions to its management team and board of directors. The Company believes the changes and additions to its team will help position it to commercialize its lead product candidate, ContraPest. ContraPest is an innovative technology for managing rodent pest populations through fertility as opposed to a lethal approach. SenesTech submitted ContraPest to the EPA for registration in 2015, and though there can be no assurance, the Company is hopeful of obtaining a positive determination in 2016.Continue reading→

8-week paid summer program pairs students with TGen researchers in significant efforts to benefit patientsContinue reading→

The licensed technology can increase global access to gene therapy through lower costs and shortened regulatory timelinesContinue reading→

Colorectal cancer biotech Cancer Prevention Pharmaceuticals files for a $29 million IPOContinue reading→

Looking to give back before year end? Check out the AZBio Annual Giving GuideContinue reading→

Arizona State University Regents’ Professor and research scientist Charles Arntzen, Ph.D., has been named a Fellow of the National Academy of Inventors (NAI).Continue reading→

This is the tenth patent for PanAridusContinue reading→

Arizona Innovation Challenge winner, Beacon Biomedical Inc. is a medical diagnostic device company on a mission…to save as many lives as possible by providing easy, accurate and affordable blood tests for earlier cancer detection.

Continue reading→

The Arizona Commerce Authority (ACA) has named six innovative early-stage companies as winners in the Fall 2015 round of the Arizona Innovation Challenge (AIC), its bi-annual business plan competition.

Continue reading→

Dr. Marvin J. Slepian and James Wyant join those who have impacted quality of life, economic development and the welfare of society.Continue reading→